# Transcarent

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/transcarent

- Industry: Healthcare IT
- Headquarters: Denver, US
- Website: www.transcarent.com/
- Total disclosed funding: $428M
- Latest round: Series D (May 2, 2024)
- Investors on record: 17

## About

Founded in 2020 by its CEO, Glen Tullman and based in Colorado, US, Transcarent, Inc. operates as a healthcare platform that provides digital access to health benefits, on-demand care teams and a health ecosystem. In January 2025, Transcarent, Inc. raised venture funding co-led by 62 Ventures and General Catalyst Partners.

The company offers an integrated platform for managing employee health benefits and care services, combining benefits navigation, clinical guidance, and on-demand care. Powered by generative AI, the platform includes WayFinding to guide users through their health journeys, integrating virtual and in-person care. It addresses needs such as cancer care, weight health, pharmacy care, and mental health, providing instant answers, provider access, and personalized guidance from Health Guides.

Transcarent generates revenue by offering a comprehensive health and care platform tailored for self-insured employers, health plans, and their members. Its revenue streams include at-risk pricing models, strategic partnerships with health systems, and bundled payments for services like surgery, pharmacy, mental health, and cancer care.

The organization plans to transform healthcare delivery through AI-powered innovation, strategic acquisitions, and platform expansion.

## Funding rounds

- Series D, May 2, 2024, $126M — Alta Partners, General Catalyst Partners, Merck Global Health Innovation Fund, Kinnevik, 7wireVentures, Memorial Hermann Health System Foundation, Ally Bridge Group, Geodesic Capital, Leaps by Bayer, Threshold Ventures, Human Capital
- Series C, Jan 11, 2022, $200M — Alta Partners, General Catalyst Partners, Merck Global Health Innovation Fund, Kinnevik, GreatPoint Ventures, 7wireVentures, Ally Bridge Group, Jove Equity Partners, Northwell Holdings, Intermountain Ventures, Threshold Ventures, Human Capital, Rush University Medical Center
- Series B, Jun 10, 2021, $58M — Alta Partners, Kleiner Perkins, General Catalyst Partners, Merck Global Health Innovation Fund, GreatPoint Ventures, 7wireVentures, Jove Equity Partners, Leaps by Bayer, Threshold Ventures
- Series A, Oct 22, 2020, $44M — Alta Partners, General Catalyst Partners, 7wireVentures

## Investors

- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series A, Series B, Series C, Series D
- General Catalyst Partners (https://capitalatlas.ai/funds/general-catalyst-partners) — Series A, Series B, Series C, Series D
- 7wireVentures (https://capitalatlas.ai/funds/7wireventures) — Series A, Series B, Series C, Series D
- Kleiner Perkins (https://capitalatlas.ai/funds/kleiner-perkins) — Series B
- Merck Global Health Innovation Fund (https://capitalatlas.ai/funds/merck-global-health-innovation-fund) — Series B, Series C, Series D
- GreatPoint Ventures (https://capitalatlas.ai/funds/greatpoint-ventures) — Series B, Series C
- Jove Equity Partners — Series B, Series C
- Leaps by Bayer (https://capitalatlas.ai/funds/leaps-by-bayer) — Series B, Series D
- Threshold Ventures (https://capitalatlas.ai/funds/threshold-ventures) — Series B, Series C, Series D
- Kinnevik (https://capitalatlas.ai/funds/kinnevik) — Series C, Series D
- Ally Bridge Group (https://capitalatlas.ai/funds/ally-bridge-group) — Series C, Series D
- Northwell Holdings (https://capitalatlas.ai/funds/northwell-holdings) — Series C
- Intermountain Ventures (https://capitalatlas.ai/funds/intermountain-ventures) — Series C
- Human Capital (https://capitalatlas.ai/funds/human-capital) — Series C, Series D
- Rush University Medical Center — Series C
- Memorial Hermann Health System Foundation — Series D
- Geodesic Capital (https://capitalatlas.ai/funds/geodesic-capital) — Series D